In vivo RAF signal transduction as a potential biomarker for sorafenib efficacy in patients with neuroendocrine tumours

por Quintela-Fandino, M, Krzyzanowska, M, Duncan, G, Young, A, Moore, M J, Chen, E X, Stathis, A, Colomer, R, Petronis, J, Grewal, M, Webster, S, Wang, L, Siu, L L
Publicado 2013